Archive for the ‘Cardiovascular / Cardiology’ Category
Thursday, March 11th, 2010
HealthHelp, a leading specialty benefit management provider, continues to target health care cost drivers by adding diagnostic cardiac catheterization to its well-established and effective suite of services...
Tuesday, March 9th, 2010
Evaluating children for underlying heart problems before prescribing stimulant medications can identify children at risk for sudden cardiac death, but electrocardiogram (ECG) screening is of borderline cost-effectiveness compared to current practice, according to research reported in Circulation: Journal of the American Heart Association...
Monday, March 8th, 2010
Medical device pioneer Stentys announced that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS)...
Friday, March 5th, 2010
On March 4, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that its new Freedom™ driver system has received the CE Mark to power the Total Artificial Heart in Europe. "The new Freedom driver is the first wearable portable driver for powering the Total Artificial Heart," said Rodger Ford, president and CEO of SynCardia...
Thursday, March 4th, 2010
A Cedars-Sinai Heart Institute cardiologist co-authored the joint science advisory issued by the American Heart Association and the American College of Cardiology that calls for close monitoring of patients taking certain blood sugar-lowering drugs. Sanjay Kaul, M.D. co-authored the advisory about drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or Rosiglitazone (Avandia)...
Thursday, March 4th, 2010
A new Swedish-led study found that Europe's top football clubs need better treatment equipment and procedures in order to save lives of spectators who have heart attacks in large crowded venues while watching a sporting event...
Wednesday, March 3rd, 2010
St. Jude Medical, Inc. (NYSE:STJ) announced that it has received CE Mark approval for the Trifecta(TM) valve, marking the Company's launch into the market for pericardial aortic stented tissue valves. The Trifecta tissue valve is used to replace a patient's diseased, damaged or malfunctioning aortic heart valve, which controls blood flow from the heart to the rest of the body...
Wednesday, March 3rd, 2010
Heart block, AV bundle, or Bundle branch block is a disease of the electrical system of the heart, as opposed to coronary artery disease, which is a disease of the blood vessels of the heart. The heart of an individual with heart block beats irregularly and more slowly than normal...
Tuesday, March 2nd, 2010
1. Early Release: Decreasing U.S. Population Sodium Intake Could Prevent Heart Attacks, Extend Lives, and Save Billions of Dollars in Health Care Costs: Collaboration with Food Industry May Help Americans consume 3,900 mg of sodium per day, 75 percent of which comes from processed food...
Monday, March 1st, 2010
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA...
Sunday, February 28th, 2010
A large nationwide study that includes neurologists from Mayo Clinic has found that blacks are substantially less likely than whites to know that they have atrial fibrillation or to use warfarin, the most common treatment for the condition. Atrial fibrillation, an abnormal heart rhythm, significantly increases risk of stroke. Warfarin is known to reduce that risk...
Friday, February 26th, 2010
As part of John Muir Health's Minimally Invasive Thoracic Surgery program, a minimally invasive thymectomy - removal of the thymus gland - was successfully performed recently at the John Muir Medical Center - Concord Campus...
Thursday, February 25th, 2010
Cambridge Heart, Inc. (OTCBB- CAMH - News), announced that results of a clinical study presented at the 29th Annual Scientific Meeting of the Belgian Society of Cardiology in Brussels, Belgium, reinforce the value of the Microvolt T-wave Alternans (MTWA) as an accurate non-invasive test to identify patients at risk of arrhythmic events and sudden cardiac death (SCD)...
Thursday, February 25th, 2010
St. Jude Medical, Inc. (NYSE: STJ) announced its wireless PressureWire(TM) Aeris technology, which aids in the diagnosis and treatment of coronary artery blockages by measuring Fractional Flow Reserve (FFR), will now be available to hospitals using the McKesson Horizon Cardiology Hemo(TM) solution...
Thursday, February 25th, 2010
Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced that data from a 53-patient double-blind, placebo controlled trial studying the treatment of heart attack patients with Prochymal, a proprietary formulation of mesenchymal stem cells (MSCs), as well as research on the underlying mechanism of action of MSCs for cardiac repair, will be presented at the 2010 BMT Tandem Meeting. Joshua M. Hare, M.D...
Wednesday, February 24th, 2010
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA...
Wednesday, February 24th, 2010
The data are inconclusive on heart risks from a class of blood sugar-lowering drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or rosiglitazone (Avandia), but the medications should be used with close monitoring from healthcare providers according to a joint science advisory from the American College of Cardiology and the American Heart Association...
Wednesday, February 24th, 2010
Black women are at significantly increased risk for developing a potentially deadly weakening of the heart muscle around the time of childbirth, researchers report...
Tuesday, February 23rd, 2010
A new study published in the March issue of Anesthesiology raises awareness for an additional risk category for patients undergoing routine coronary artery bypass surgery - low to moderate levels of inflammation. C-reactive protein (CRP) is a recognized marker of systemic inflammation, routinely measured in patients to assess their risk for heart attack...
Tuesday, February 23rd, 2010
Dr. Richard J...
Monday, February 22nd, 2010
An international research team has identified a common gene variant associated with a form of the irregular heartbeat called atrial fibrillation...